Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers…
Read More →
On November 11 at 9:18 p.m., my phone erupted with the dings of incoming text messages advising me to go…
Read More →
The U.S. Food and Drug Administration (FDA) announced the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or “TEMPO…
Read More →
On December 8, the CFTC announced a series of actions to provide regulatory clarity and support responsible innovation in digital…
Read More →
Last week, Massachusetts’ Supreme Judicial Court delved into a case with potentially national implications: should Meta platforms face a lawsuit…
Read More →
In a historic legal outcome, the national trial firm Robins Kaplan LLP announced it has secured a $5 million compensatory…
Read More →
In 1995, the Michigan Legislature enacted its Drug Immunity Law, which provided an absolute defense for pharmaceutical companies in product…
Read More →
When a company brings a new product to market, who has the authority to approve the product’s label and associated…
Read More →
Rule 45(c) of the Federal Rules of Civil Procedure protects witnesses from being compelled to travel long distances to testify…
Read More →
Understanding the Link Between Depo-Provera and Meningioma – In recent years, several major medical studies have identified a potential association…
Read More →